Podcasts about kuter

Nasza dzisiejsza rozmowa będzie krążyć wokół pytania, którego jeszcze chyba nie zadawaliśmy sobie w tym podcaście. Czy analogowy sprzęt jest lepszy od wtyczek? Czy używanie analogowych rozwiązań znacznie zwiększa koszt produkcji utworu? Jak korzystanie z tych rozwiązań wpływa na proces kreatywny? O tym wszystkim rozmawiamy dzisiaj z Kubą Kuterą.Jeśli chcesz wesprzeć naszą pracę zapraszamy na https://buycoffee.to/cierpieniamlodegomuzykaKuba na Ig: https://www.instagram.com/kuba_kutera/

The UH Football team, coming off their first road win under the Timmy Chang Coaching regime, looks to keep the General Kuter Trophy at home as they play Air Force on Saturday, November 11th. It's “Military Day” at the Clarence T.C. Ching Athletics Complex, and Les Murakami Stadium for Hawai‘i's Finest presents “Kickoff at the Les.” First Hawaiian Bank is the game sponsor and will distribute 750 rally towels at Gate B. A F-22 flyover will occur during pre-game. Mahalo to Spectrum, Battery Bill's, and HawaiiUSA FCU for sponsoring Hawaii Football Now!The UH Football team, coming off their first road win under the Timmy Chang Coaching regime, looks to keep the General Kuter Trophy at home as they play Air Force on Saturday, November 11th. It's “Military Day” at the Clarence T.C. Ching Athletics Complex, and Les Murakami Stadium for Hawai‘i's Finest presents “Kickoff at the Les.” First Hawaiian Bank is the game sponsor and will distribute 750 rally towels at Gate B. A F-22 flyover will occur during pre-game. Mahalo to Spectrum, Battery Bill's, and HawaiiUSA FCU for sponsoring Hawaii Football Now!

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Go online to PeerView.com/DBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this Peerview “Clinical Consults” based on an immune thrombocytopenia (ITP) symposium at the 2023 ASCO Annual Meeting, experts will focus on preparing learners for the emergence of innovative, BTK inhibitor-based strategies with therapeutic applications in ITP. Throughout, the experts will use conversational, case-centered discussions to explore the persistent challenges in ITP management; the mechanistic rationale and evidence for the use of reversible BTK inhibitors; and the application of new evidence that can be used to update standard ITP protocols, particularly for patients relapsing after prior treatment. Watch this recording to see if you are prepared to implement the new rules for management of ITP! Upon completion of this activity, participants should be better able to: Describe the unmet needs and current clinical burden of ITP management, including lack of durable remissions, the challenges of multiple relapses, and symptoms such as fatigue and anxiety over bleeding; Cite the mechanistic rationale, efficacy, and safety evidence supporting the use of BTK inhibitors in patients with previously treated ITP; Integrate newer therapeutics, including BTK inhibitor-based options, into the management of adults and adolescents with persistent and chronic ITP; and Address practical aspects related to the use of innovative therapeutics in ITP, including management of unique dosing and safety considerations; attention to patient quality of life; and provision of education to patients requiring therapy for relapsed disease.

Dr. Brian Laslie, Command Historian of the United States Air Force Academy, joins me in this episode to talk about General Laurence S. Kuter ("it's pronounced like pewter"), the subject of one of his books. It's a fun episode full of personal stories about Larry Kuter and his wife, how Dr. Laslie came to write this book, and insights into just how integral Kuter was to the birth of the modern Air Force. Links: Architect of Air Power: General Laurence S. Kuter and the Birth of the US Air Force (Amazon Affiliate Link https://amzn.to/4346O30) The Air Force Way of War: US Tactics and Training After Vietnam (Amazon Affiliate Link https://amzn.to/3XsVZ9G) Air Power's Lost Cause: The American Air Wars of Vietnam (Amazon Affiliate Link https://amzn.to/3Nwnvyo) Victory Through Air Power (Amazon Affiliate Link https://amzn.to/3prbFOa) Victory Through Air Power (https://www.youtube.com/watch?v=tUeKeN9bXSE) From Balloons to Drones: Air Power Throughout the Ages (website https://balloonstodrones.com/ and podcast https://balloonstodrones.com/podcasts/) http://www.motheroftanks.com/ads-sponsors-and-affiliate-links/ --- Send in a voice message: https://podcasters.spotify.com/pod/show/mother-of-tanks/message

Cenimy sobie stabilizację, unikamy ryzyka. Jak wynika z nowych badań - niemal dwa razy więcej osób jest zwolennikami pracy na etacie niż "na swoim". Mimo to ich nastawienie do prowadzenia biznesu jest raczej pozytywne. A młodzi mają dużą szansę na sukces... O czym powiedzą Łukasz Blichewicz z Assay Group i prof. Dominika Maison z Uniwersytetu Warszawskiego. Rozmawia Miłosz Kuter. Find out more at https://3-grosze-o-ekonomii.pinecast.co

Büyükada'da “meydanın hafızası”na gönderme yapan yerleştirmelere imza atan Adalı sanatçılar; Ayşem Ötük, Çiğdem Üçüncü, Ebru Akıncı, Fatma Sağ Tunçalp, Fikret Parlak, Gül Bolulu, Gülce Kuter, Metin Özkara, Sevgi Çekiç, Zeynep Soref konuklarımız. 

Gen. Laurence Kuter, was instrumental in the founding of the Air Force. Though not your typical "ace flyer", his organizational abilities and expert handling of crises - placed him at critical junctures in our 20th century military history. You'll hear how he was a key participant in many historical events, spanning pre-WW2 through the Cold War, and finishing his career as the 2nd commander of NORAD.  His fascinating life will be presented by Dr. Brian Laslie, currently the Command Historian at the United State Air Force Academy. You will also hear about Kuter's wife, Ethel Lyddon Kuter, who was both a true partner and accomplished in her own right. Laslie's biography on Kuter, "Architect of Air Power",  can be found on Amazon at this link. He also is a content contributor to the podcast series - From Balloons to Drones, which explores the development of airpower. Images related to this podcast can be found at the Instagram account - phihpod. 

Couch Potato Theater: THE LAST STARFIGHTER (1984)  Greetings, Starfighter. You have been recruited by the Star League to defend the frontier against Xur and the Ko-Dan armada. Welcome to Couch Potato Theater here on the Fandom Podcast Network. On Couch Potato Theater we celebrate our favorite movies! You may own your favorite movies digitally, or on physical media. However when they air on your cable TV, you love what you are watching so much, you don't get off the couch! And that's the definition of what Couch Potato Theater is all about. On the special episode of Couch Potato Theater, your hosts Kevin Reitzel, Kyle Wagner, Lacee Aderhold and Alex Autrey discuss one of the most fun, fan favorite cult movies of all time, THE LAST STARFIGHTER (1984). VICTORY OR DEATH! The Last Starfighter is directed by Nick Castle. The film tells the story of Alex Rogan (Lance Guest), a teenage video game expert who finds himself transported to another planet after conquering The Last Starfighter video game only to find out it was just a test. He was recruited to join the team of best starfighters to defend their world from the attack. It film also features Robert Preston, Dan O'Herlihy, Catherine Mary Stewart, Norman Snow, and Kay E. Kuter. Fandom Podcast Network Contact Information - The FANDOM PODCAST NETWORK YouTube Channel:  https://www.youtube.com/c/FandomPodcastNetwork - Master feed for all FPNet Audio Podcasts: http://fpnet.podbean.com/ - Facebook: https://www.facebook.com/Fandompodcastnetwork - Email: fandompodcastnetwork@gmail.com - Instagram: https://www.instagram.com/fandompodcastnetwork/ - Twitter: @fanpodnetwork / https://twitter.com/fanpodnetwork FPN Couch Potato Theater Host & Guest Contact Info: - Kyle Wagner. on Twitter: @AKyleW / Instagram: @Akylefandom - Kevin Reitzel. on Twitter & Instagram: @spartan_phoenix - Alex Autrey on Twitter: @7thRowCenter - Lacee Aderhold on Twitter: @LaceePants / Instagram: @thelaceepants   - Tee Public Fandom Podcast Network Store:  https://www.teepublic.com/stores/fandom-podcast-network

Jacaranda FM — Gender-based violence is devastating South Africa. And while perpetrators roam the streets without conviction, their victims are burdened with the experience long after it’s over. Leilani Kuter was raped and left for dead when she was 18 years old. Twenty-seven years later, she’s still coming to terms with it. “Humans are not made to carry this pain with us,” Kuter says. She recently completed a 729-kilometre walk over 27 days to empower herself and others. “You cannot run from trauma, but you can run to prevent it,” Kuter says. On her journey, she wore a yellow shirt – the colour her attacker was wearing at the time of the assault. It symbolised Kuter’s strength and her decision to take back her power. What was once a trigger no longer hurts her, and Kuter aims to help others feel that liberation. “I want to be a voice for survivors and make a difference,” she says. Kuter has since raised over R200 000 to purchase comfort packs for people when they report an assault, as well as sponsor counselling and rehabilitation sessions. “As survivors, we need to unite,” she says. “We are not our trauma.” We all have the power within us to put our foot down, shed the pain that remains from our past, and move forward. Beautiful News

John Serpico of ImprovAdvice and True Tales of the Illuminati joins us to talk about commercials related to The Last Starfighter! And a bit more about the movie itself. While researching this movie, we learned that Kay E. Kuter, who played Enduran in The Last Starfighter, was the voice of Hershey’s Kisses for 14 years. So naturally we had to hunt down some kiss commercials! We started in 1984 because that’s when The Last Starfighter came out.“Edna Slips a Kiss” 1984 commercial: This one doesn’t have Kay E. Kuter, but it does show the primary thesis of this 80s campaign, which is that Hershey’s Kisses are signs of affection. And a sad klutzy kid gets a Kiss from his mom in this other commercial from 1984Like the human equivalent of a Pound Puppy. We hope this kid grew up to be okay! Is this you? Are you okay? Let us know!Hershey’s Kisses Christmas bells commercialJohn told us that he heard this is the same ad they use every year, and they pay employees bonuses with the money they save by not making new ones. We finally moved into the 90s and Kay E. Kuter’s run, and watched this 1996 ice skating Kisses commercial. Kay E. Kuter comes in at the very end of this one, and WOW, what a voice! Finally, we watched this sci-fi Almond Kisses commercial, also featuring Kuter.How do almonds get into Kisses? Space Impressment!!!Since our conversation on commercials was so short, we decided to include some deep dive conversation about The Last Starfighter that didn’t quite make it into the main episode. Deleted Scenes, if you will! And then we ended on a bit of a heartwarming note! John thanked us for helping him not hate this movie as much, and we also talked about how great it was that John brought us some delicious sticky buns from Flour, one of Boston’s celebrated bakeries. Then John told us that Chef Chang of Flour actually beat Bobby Flay in a sticky bun throw down! John had to leave at that point since we’d kept him in our clutches for Quite A While, but we hunted down a video of Bobby Flay praising Flour’s sticky buns and watched it on our own. Mmm, sticky buns… Thanks again, John!If you’re having fun listening to us, please tell your friends about us! Subscribe to our newsletter at thisiswhywerelikethis.substack.com for free, or pay $5/month to get access to two bonus paid episodes each month! We’re also on Patreon if that’s your jam! Rate and review us! follow us on Twitter where we’re @thisiswhy_pod! And, of course, you can always drop us a note at at thisiswhywerelikethis@gmail.com. This is a public episode. Get access to private episodes at thisiswhywerelikethis.substack.com/subscribe

John Serpico of ImprovAdvice and True Tales of the Illuminati joins us to talk about commercials related to The Last Starfighter! And a bit more about the movie itself. While researching this movie, we learned that Kay E. Kuter, who played Enduran in The Last Starfighter, was the voice of Hershey's Kisses for 14 years. So naturally we had to hunt down some kiss commercials! We started in 1984 because that's when The Last Starfighter came out."Edna Slips a Kiss" 1984 commercial: This one doesn't have Kay E. Kuter, but it does show the primary thesis of this 80s campaign, which is that Hershey's Kisses are signs of affection. And a sad klutzy kid gets a Kiss from his mom in this other commercial from 1984Like the human equivalent of a Pound Puppy. We hope this kid grew up to be okay! Is this you? Are you okay? Let us know!Hershey's Kisses Christmas bells commercialJohn told us that he heard this is the same ad they use every year, and they pay employees bonuses with the money they save by not making new ones. We finally moved into the 90s and Kay E. Kuter's run, and watched this 1996 ice skating Kisses commercial. Kay E. Kuter comes in at the very end of this one, and WOW, what a voice! Finally, we watched this sci-fi Almond Kisses commercial, also featuring Kuter.How do almonds get into Kisses? Space Impressment!!!Since our conversation on commercials was so short, we decided to include some deep dive conversation about The Last Starfighter that didn't quite make it into the main episode. Deleted Scenes, if you will! And then we ended on a bit of a heartwarming note! John thanked us for helping him not hate this movie as much, and we also talked about how great it was that John brought us some delicious sticky buns from Flour, one of Boston's celebrated bakeries. Then John told us that Chef Chang of Flour actually beat Bobby Flay in a sticky bun throw down! John had to leave at that point since we'd kept him in our clutches for Quite A While, but we hunted down a video of Bobby Flay praising Flour's sticky buns and watched it on our own. Mmm, sticky buns… Thanks again, John!If you're having fun listening to us, please tell your friends about us! Subscribe to our newsletter at thisiswhywerelikethis.substack.com for free, or pay $5/month to get access to two bonus paid episodes each month! We're also on Patreon if that's your jam! Rate and review us! follow us on Twitter where we're @thisiswhy_pod! And, of course, you can always drop us a note at at thisiswhywerelikethis@gmail.com. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit thisiswhywerelikethis.substack.com/subscribe

Sean Bean (or someone doing a terrible impression) drops in on Pete & Fran for a baking lesson. After this disaster they watch 1984's 'The Last StarFighter' before speaking to Abraham Lincoln about the use of hot air balloons. SHOW NOTES Seann Bean (born 17 April 1959), is an English actor. Bean made his professional debut in a theatre production of Romeo and Juliet in 1983. He first found mainstream success for his portrayal of Richard Sharpe in the ITV series Sharpe. Further roles followed, including Patriot Games (1992), GoldenEye (1995), Ronin (1998), The Lord of the Rings trilogy (2001–2003), Equilibrium (2002), National Treasure (2004), Odysseus in Troy (2004), The Island (2005), Jupiter Ascending (2015) and The Martian (2015). The Last Starfighter is a 1984 American space opera film directed by Nick Castle. The film tells the story of Alex Rogan (Lance Guest), an average teenager recruited by an alien defense force to fight in an interstellar war. It also features Robert Preston, Dan O'Herlihy, Catherine Mary Stewart, Norman Snow, and Kay E. Kuter. Abraham Lincoln (February 12, 1809 – April 15, 1865) was an American statesman and lawyer who served as the 16th president of the United States from March 1861 until his assassination in April 1865

Episode 15   Host David Henry, MD, welcomes David J. Kuter, MD, of Harvard and Massachusetts General Hospital to talk about idiopathic thrombocytopenic purpura. He answers questions like: what are the causes? When do you treat? In Clinical Correlation this week, Ilana Yurkiewicz, MD, explores pregnant patients.    Show notes By Hitomi Hosoya, MD, PhD, resident in the department of internal medicine, Pennsylvania Hospital of the University of Pennsylvania Health System, Philadelphia   Causes of idiopathic thrombocytopenic purpura : Secondary causes include chronic lymphocytic leukemia, lymphoma, and autoimmune conditions and account for 30%-50% of ITP. Idiopathic ITP is associated with pregnancy, post-viral infection, and vaccination and accounts for 50%-75% of ITP.   Pathophysiology: Antibodies attach to platelets, which are cleared by the liver or spleen (increased consumption). T cells or B cells attack bone marrow (reduced production).   When to treat: Major bleeding. Platelet count less than 20 x 109/L.   Initial treatment: Corticosteroids (dexamethasone or prednisone). These drugs should not be used for more than 6 weeks. Intravenous immunoglobulin is appropriate with major bleeding or when a patient requires immediate surgery.   Subsequent treatment: Platelet count less than 20 x 109/L during steroid taper. Rituximab (50%-70% response rate). Thrombopoietin receptor agonist (90% response rate); eltrombopag (oral) or romiplostim (subcutaneous).

We have all seen pictures of the “Big Three” (Churchill, Roosevelt, Stalin) at their historic meeting Yalta in February 1945. The three leaders command the viewer’s attention, naturally, but in the background of the various versions of that photo are other important figures. One can glimpse George Marshall in some. Foreign ministers Eden and Molotov appear in others. American Admirals King and Leahy are there. And so is a U.S. Army Air Force general named Larry Kuter. Not exactly a household name, Kuter was an enormously influential figure, who richly deserves this excellent biography written by airpower expert, Brian Laslie: Architect of Air Power: General Laurence S. Kuter and the Birth of the U.S. Air Force (University Press of Kentucky, 2017). Dr. Laslie is the Deputy Command Historian at NORAD and US Northern Command and the author of another noteworthy book on the U.S. Air Force: The Air Force Way of War: U.S. Tactics and Training after Vietnam (2015), which I can also recommend. Laslie kept encountering Kuter’s name or photo as his work took him to Air Force bases and installations around the world and began to ask questions. Kuter was the co-author of AWPD-1, the first American plan for air war and a strong proponent of daylight, precision strategic bombing. He commanded American forces all over the world, served immediately under Harold George in the postwar Air Transport Command, which gave him responsibility, among other things, for the Berlin Airlift in 1948. He set up the United States Air Force Academy; he commanded NORAD; in retirement, he worked with Pan Am on the 747 project. And there was much more to Kuter’s story, as you can read in Laslie’s book after you enjoy our conversation here. Listeners might also be interested in the author’s blog, Balloons to Drones.   Learn more about your ad choices. Visit megaphone.fm/adchoices

We have all seen pictures of the “Big Three” (Churchill, Roosevelt, Stalin) at their historic meeting Yalta in February 1945. The three leaders command the viewer’s attention, naturally, but in the background of the various versions of that photo are other important figures. One can glimpse George Marshall in some. Foreign ministers Eden and Molotov appear in others. American Admirals King and Leahy are there. And so is a U.S. Army Air Force general named Larry Kuter. Not exactly a household name, Kuter was an enormously influential figure, who richly deserves this excellent biography written by airpower expert, Brian Laslie: Architect of Air Power: General Laurence S. Kuter and the Birth of the U.S. Air Force (University Press of Kentucky, 2017). Dr. Laslie is the Deputy Command Historian at NORAD and US Northern Command and the author of another noteworthy book on the U.S. Air Force: The Air Force Way of War: U.S. Tactics and Training after Vietnam (2015), which I can also recommend. Laslie kept encountering Kuter’s name or photo as his work took him to Air Force bases and installations around the world and began to ask questions. Kuter was the co-author of AWPD-1, the first American plan for air war and a strong proponent of daylight, precision strategic bombing. He commanded American forces all over the world, served immediately under Harold George in the postwar Air Transport Command, which gave him responsibility, among other things, for the Berlin Airlift in 1948. He set up the United States Air Force Academy; he commanded NORAD; in retirement, he worked with Pan Am on the 747 project. And there was much more to Kuter’s story, as you can read in Laslie’s book after you enjoy our conversation here. Listeners might also be interested in the author’s blog, Balloons to Drones.   Learn more about your ad choices. Visit megaphone.fm/adchoices

We have all seen pictures of the “Big Three” (Churchill, Roosevelt, Stalin) at their historic meeting Yalta in February 1945. The three leaders command the viewer’s attention, naturally, but in the background of the various versions of that photo are other important figures. One can glimpse George Marshall in some. Foreign ministers Eden and Molotov appear in others. American Admirals King and Leahy are there. And so is a U.S. Army Air Force general named Larry Kuter. Not exactly a household name, Kuter was an enormously influential figure, who richly deserves this excellent biography written by airpower expert, Brian Laslie: Architect of Air Power: General Laurence S. Kuter and the Birth of the U.S. Air Force (University Press of Kentucky, 2017). Dr. Laslie is the Deputy Command Historian at NORAD and US Northern Command and the author of another noteworthy book on the U.S. Air Force: The Air Force Way of War: U.S. Tactics and Training after Vietnam (2015), which I can also recommend. Laslie kept encountering Kuter’s name or photo as his work took him to Air Force bases and installations around the world and began to ask questions. Kuter was the co-author of AWPD-1, the first American plan for air war and a strong proponent of daylight, precision strategic bombing. He commanded American forces all over the world, served immediately under Harold George in the postwar Air Transport Command, which gave him responsibility, among other things, for the Berlin Airlift in 1948. He set up the United States Air Force Academy; he commanded NORAD; in retirement, he worked with Pan Am on the 747 project. And there was much more to Kuter’s story, as you can read in Laslie’s book after you enjoy our conversation here. Listeners might also be interested in the author’s blog, Balloons to Drones.   Learn more about your ad choices. Visit megaphone.fm/adchoices

We have all seen pictures of the “Big Three” (Churchill, Roosevelt, Stalin) at their historic meeting Yalta in February 1945. The three leaders command the viewer’s attention, naturally, but in the background of the various versions of that photo are other important figures. One can glimpse George Marshall in some. Foreign ministers Eden and Molotov appear in others. American Admirals King and Leahy are there. And so is a U.S. Army Air Force general named Larry Kuter. Not exactly a household name, Kuter was an enormously influential figure, who richly deserves this excellent biography written by airpower expert, Brian Laslie: Architect of Air Power: General Laurence S. Kuter and the Birth of the U.S. Air Force (University Press of Kentucky, 2017). Dr. Laslie is the Deputy Command Historian at NORAD and US Northern Command and the author of another noteworthy book on the U.S. Air Force: The Air Force Way of War: U.S. Tactics and Training after Vietnam (2015), which I can also recommend. Laslie kept encountering Kuter’s name or photo as his work took him to Air Force bases and installations around the world and began to ask questions. Kuter was the co-author of AWPD-1, the first American plan for air war and a strong proponent of daylight, precision strategic bombing. He commanded American forces all over the world, served immediately under Harold George in the postwar Air Transport Command, which gave him responsibility, among other things, for the Berlin Airlift in 1948. He set up the United States Air Force Academy; he commanded NORAD; in retirement, he worked with Pan Am on the 747 project. And there was much more to Kuter’s story, as you can read in Laslie’s book after you enjoy our conversation here. Listeners might also be interested in the author’s blog, Balloons to Drones.   Learn more about your ad choices. Visit megaphone.fm/adchoices

We have all seen pictures of the “Big Three” (Churchill, Roosevelt, Stalin) at their historic meeting Yalta in February 1945. The three leaders command the viewer’s attention, naturally, but in the background of the various versions of that photo are other important figures. One can glimpse George Marshall in some. Foreign ministers Eden and Molotov appear in others. American Admirals King and Leahy are there. And so is a U.S. Army Air Force general named Larry Kuter. Not exactly a household name, Kuter was an enormously influential figure, who richly deserves this excellent biography written by airpower expert, Brian Laslie: Architect of Air Power: General Laurence S. Kuter and the Birth of the U.S. Air Force (University Press of Kentucky, 2017). Dr. Laslie is the Deputy Command Historian at NORAD and US Northern Command and the author of another noteworthy book on the U.S. Air Force: The Air Force Way of War: U.S. Tactics and Training after Vietnam (2015), which I can also recommend. Laslie kept encountering Kuter’s name or photo as his work took him to Air Force bases and installations around the world and began to ask questions. Kuter was the co-author of AWPD-1, the first American plan for air war and a strong proponent of daylight, precision strategic bombing. He commanded American forces all over the world, served immediately under Harold George in the postwar Air Transport Command, which gave him responsibility, among other things, for the Berlin Airlift in 1948. He set up the United States Air Force Academy; he commanded NORAD; in retirement, he worked with Pan Am on the 747 project. And there was much more to Kuter’s story, as you can read in Laslie’s book after you enjoy our conversation here. Listeners might also be interested in the author’s blog, Balloons to Drones.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Leilani se positiewe energie en houding is aansteeklik! Haar nuutste besigheid, Date Night SA, het al amper 200,000 Facebook volgelinge. Kom luister hoe alles begin het en meer belangrik, hoe sy die wêreld 'n beter plek maak vir elke R1 wat sy verdien. Hierdie episode word moontlik gemaak deur ons nuwe borg EXAH. Webwerf

Leilani se positiewe energie en houding is aansteeklik! Haar nuutste besigheid, Date Night SA, het al amper 200,000 Facebook volgelinge. Kom luister hoe alles begin het en meer belangrik, hoe sy die wêreld 'n beter plek maak vir elke R1 wat sy verdien. Hierdie episode word moontlik gemaak deur ons nuwe borg EXAH. exah

CliffCentral.com — Leilani se positiewe energie en houding is aansteeklik! Haar nuutste besigheid, Date Night SA, het al amper 200,000 Facebook volgelinge. Kom luister hoe alles begin het en meer belangrik, hoe sy die wêreld 'n beter plek maak vir elke R1 wat sy verdien. Hierdie episode word moontlik gemaak deur ons nuwe borg EXAH. exah

Jacques Basson — Leilani se positiewe energie en houding is aansteeklik! Haar nuutste besigheid, Date Night SA, het al amper 200,000 Facebook volgelinge. Kom luister hoe alles begin het en meer belangrik, hoe sy die wêreld 'n beter plek maak vir elke R1 wat sy verdien. Hierdie episode word moontlik gemaak deur ons nuwe borg EXAH.

In this episode the guys are gearing up for the 31st annual Survivor Series, where Raw and SmackDown go head-to-head to determine which brand reigns supreme, as well as NXT Takeover War Games. Credo & Angry Kuter give their predictions and speculate what's to come on this huge weekend! Kuter also brings Credo to "Mark Court" to defend Charlotte Flair's new reign as Smackdown's Women Champion. It's also time to celebrate the release of James Ellsworth! All this and a whole lot more!

Mick chats with Brian Laslie, a historian for the North American Aerospace Defense Command and United States Northern Command. They chat about his new book, Architect of Airpower: General Laurence S. Kuter and the Birth of the US Air Force. Brian also discusses airpower and the development of the modern US Airforce. Brian offers an interesting answer to the final question.  You can get your show swag here or support the show here.